1. Home
  2. ACOG vs ORMP Comparison

ACOG vs ORMP Comparison

Compare ACOG & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$8.86

Market Cap

193.6M

Sector

N/A

ML Signal

HOLD

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$4.66

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACOG
ORMP
Founded
2000
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.6M
170.3M
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
ACOG
ORMP
Price
$8.86
$4.66
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
162.7K
218.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
6.51%
EPS Growth
41.58
412.50
EPS
N/A
2.76
Revenue
$10,220,275.00
$2,000,000.00
Revenue This Year
$139.22
N/A
Revenue Next Year
$134.48
N/A
P/E Ratio
N/A
$1.73
Revenue Growth
N/A
49.25
52 Week Low
$4.50
$2.09
52 Week High
$10.14
$5.47

Technical Indicators

Market Signals
Indicator
ACOG
ORMP
Relative Strength Index (RSI) 47.57 50.75
Support Level $5.28 $3.91
Resistance Level $9.04 $5.10
Average True Range (ATR) 0.55 0.24
MACD -0.09 -0.04
Stochastic Oscillator 3.91 13.58

Price Performance

Historical Comparison
ACOG
ORMP

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: